GlassScriptPhysician profile
Alexander J Boyle
NPI 1558603761
$2,835.87
in general payments reported to CMS, 2019-2025
28 companies · $382 in 2025
The $382 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $321 · 2021: $326 · 2022: $314 · 2023: $724 · 2024: $325 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,331 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,330.96 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $505.27 | 2019-2025 | Titan |
| Axonics, INC. | $338.78 | 2021-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $315.60 | 2019-2024 | Ams 700, Spaceoar Vue System - 10ml |
| Procept Biorobotics Corporation | $299.38 | 2022-2024 | Aquabeam Robotic System, Aquabeam System |
| Astellas Pharma US INC | $246.75 | 2019-2023 | |
| Endo Pharmaceuticals INC. | $231.71 | 2019-2023 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $118.86 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $105.66 | 2022-2025 | |
| Janssen Biotech, INC. | $94.27 | 2019-2024 | Erleada |
| Abbvie INC. | $71.07 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $66.06 | 2019-2025 | |
| Endo USA, INC. | $53.97 | 2024-2025 | Xiaflex |
| Neotract INC. | $45.46 | 2020 | |
| Olympus America INC. | $43.02 | 2025 | Itind System |
| Calyxo, INC. | $37.95 | 2025 | Cvac Aspiration System |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $33.40 | 2025 | Eligard |
| Teleflex LLC | $31.91 | 2022-2025 | Barrigel |
| Dendreon Pharmaceuticals LLC | $30.49 | 2020 | |
| Medtronic USA, INC. | $21.48 | 2019 | |
| Metuchen Pharmaceuticals | $21.15 | 2019 | |
| Travere Therapeutics, INC. | $19.76 | 2019 | |
| Medtronic, INC. | $19.65 | 2024 | Interstim |
| Tolmar Pharmaceuticals, INC. | $17.25 | 2021 | |
| Cycle Pharmaceuticals INC | $16.63 | 2025 | Venxxiva |
| Cook Medical LLC | $14.32 | 2019 | |
| Acerus Pharmaceuticals Corporation | $13.54 | 2021 | |
| Ferring Pharmaceuticals INC. | $11.47 | 2019 | |
| Dentsply Ih INC. | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Boyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.